JP2008505709A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008505709A5 JP2008505709A5 JP2007520517A JP2007520517A JP2008505709A5 JP 2008505709 A5 JP2008505709 A5 JP 2008505709A5 JP 2007520517 A JP2007520517 A JP 2007520517A JP 2007520517 A JP2007520517 A JP 2007520517A JP 2008505709 A5 JP2008505709 A5 JP 2008505709A5
- Authority
- JP
- Japan
- Prior art keywords
- sealant
- cross
- linked
- tissue
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Claims (29)
被験者に治療法を施し得るようにされた、システム。 The system of claim 1, wherein
A system that allows a subject to be treated.
被験者にて診断を実行し得るようにされた、システム。 The system of claim 1, wherein
A system that allows a subject to perform a diagnosis.
シーラントの送り出し要素は、標的組織にて治療法を実行する前に、シーラントをターゲット組織まで送り出し得るようにされる、システム。 The system of claim 1, wherein
A system wherein the sealant delivery element is adapted to deliver the sealant to the target tissue prior to performing a treatment on the target tissue.
シーラントの送り出し要素は、システムを除去したとき、シーラントをアクセス穴まで送り出し得るようにされる、システム。 The system of claim 1, wherein
A system wherein the sealant delivery element is adapted to deliver sealant to the access hole when the system is removed.
シーラントの送り出し要素は、標的組織にて診断を実行する前に、シーラントをターゲット組織まで送り出し得るようにされる、システム。 The system of claim 1, wherein
A system wherein the sealant delivery element is adapted to deliver sealant to the target tissue prior to performing a diagnosis on the target tissue.
細長い本体は、末端と、基端とを有し、該末端は組織を切開又は切除する（ｅｘｃｉｓｉｎｇ）切断要素（ｃｕｔｔｉｎｇ ｅｌｅｍｅｎｔ）を備える、システム。 The system of claim 1, wherein
The elongated body has a distal end and a proximal end, the distal end comprising a cutting element for incising or excising tissue.
切断要素は、針、把持器、鉗子、メス、掻破器、鋏、ブラシ、アブレーションツール、ＲＦループ、ヒータ、レーザアブレーション、プローブ、機械的切開又は切除装置、ｘ線、放射線及び低温外科手術用プローブから成る群から選ばれた要素を備える、システム。 The system of claim 7, wherein
Cutting elements include needles, graspers, forceps, scalpels, scrapers, scissors, brushes, ablation tools, RF loops, heaters, laser ablation, probes, mechanical incision or ablation devices, x-rays, radiation and cryosurgical probes A system comprising elements selected from the group consisting of:
標的組織を映像化し得るようにされた、システム。 The system of claim 1, wherein
A system that can visualize target tissues.
調剤組成物をターゲット組織まで送り出し得るようにされた、システム。 The system of claim 1, wherein
A system adapted to deliver a dispensing composition to a target tissue.
その内部に細長い本体が配設されるスリーブを更に備える、システム。 The system of claim 1, wherein
The system further comprising a sleeve having an elongated body disposed therein.
架橋結合したシーラントは血栓形成カスケード（ｃｌｏｔｔｉｎｇ ｃａｓｃａｄｅ）を開始し又は加速する、システム。 The system of claim 1, wherein
A system in which a cross-linked sealant initiates or accelerates a clotting cascade.
シーラントは、ヒドロゲル、タンパク質、ポリマー及び架橋結合剤から成る群から選ばれた材料を備える、システム。 The system of claim 1, wherein
The sealant comprises a material selected from the group consisting of a hydrogel, a protein, a polymer, and a cross-linking agent.
ヒドロゲル材料は、ヒアルロナン（ｈｙａｌｕｒｏｎｓ）、ヒアルロン酸、アルギン酸塩、キチン、キトサン及びそれらの誘導体の群から選ばれた材料を備える、システム。 The system of claim 13, wherein
The hydrogel material comprises a material selected from the group of hyaluronan, hyaluronic acid, alginate, chitin, chitosan and derivatives thereof.
タンパク質材料は、アルブミン、豚アルブミン、コラーゲン及びゼラチンから成る群から選ばれた材料を備える、システム。 The system of claim 13, wherein
The protein material comprises a material selected from the group consisting of albumin, porcine albumin, collagen and gelatin.
ポリマー材料は、ポリ（乳酸）及びポリ（グリコリド）から成る群から選ばれた材料を備える、システム。 The system of claim 13, wherein
The polymer material comprises a material selected from the group consisting of poly (lactic acid) and poly (glycolide).
架橋結合剤材料は、グルタルアルデヒド及び安定的なポリアルデヒドから成る群から選ばれた材料を備える、システム。 The system of claim 13, wherein
The crosslinker material comprises a material selected from the group consisting of glutaraldehyde and a stable polyaldehyde.
架橋結合したシーラントは、１．３７９ｋＰａ（０．２ｐｓｉ）以上の接着力を有する、システム。 The system of claim 1, wherein
The system wherein the cross-linked sealant has an adhesion of greater than or equal to 1.379 kPa (0.2 psi).
架橋結合したシーラントは、１．３７９ｋＰａ（０．２ｐｓｉ）ないし４．１３７ｋＰａ（０．６ｐｓｉ）の範囲の接着力を有する、システム。 The system of claim 1, wherein
The cross-linked sealant has an adhesive strength in the range of 1.379 kPa (0.2 psi) to 4.137 kPa (0.6 psi).
架橋結合したシーラントは、４．１３７ｋＰａ（０．６ｐｓｉ）ないし２０．６８４ｋＰａ（３．０ｐｓｉ）の範囲の接着力を有する、システム。 The system of claim 1, wherein
The system wherein the cross-linked sealant has an adhesive strength in the range of 4.137 kPa (0.6 psi) to 20.684 kPa (3.0 psi).
架橋結合した組織シーラントは、検出可能な標識（ｌａｂｅｌ）を更に備える、システム。 The system of claim 1, wherein
The cross-linked tissue sealant further comprises a detectable label.
検出可能な標識は、酵素、放射性同位体又は発光物質である、システム。 The system of claim 21, wherein
The system wherein the detectable label is an enzyme, radioisotope or luminescent material.
架橋結合したシーラントは、１．１センチポアズ以上の粘度を有する、システム。 The system of claim 1, wherein
The system wherein the cross-linked sealant has a viscosity of 1.1 centipoise or greater.
前記細長い本体は、アクセス穴を通して肺の内側部分又は肺の取り巻く組織と接触し得るようにされ、
前記架橋結合したシーラントは、グルタルアルデヒド系シーラントを備え、
前記シーラントの送り出し要素は、グルタルアルデヒド系シーラントをアクセス穴を通して送り出し得るようにされた、前記アクセス穴を閉塞する穴閉塞要素を備える、システム。 24. A system according to any one of claims 1 to 23, wherein:
The elongate body is adapted to contact the inner part of the lung or the tissue surrounding the lung through the access hole;
The cross-linked sealant comprises a glutaraldehyde-based sealant ,
The delivery element sealant comprises been adapted to be sent out glutaraldehyde based sealant through the access hole, the hole closure element which closes the access hole, the system.
グルタルアルデヒド系シーラントは、熱処理される、システム。 25. The system of claim 24, wherein
Glutaraldehyde-based sealant is heat-treated, the system.
穴閉塞要素は、肺と胸膜との間の空間内への空気又は流体の漏洩を緩和し得るようにされた、システム。 25. The system of claim 24, wherein
Hole closure element is adapted to be alleviated air or fluid leakage into the space between the lung and pleura, system.
穴閉塞要素は、気胸（ｐｎｅｕｍｏｔｈｏｒａｘ）を緩和する、システム。 25. The system of claim 24, wherein
Hole closure element alleviates pneumothorax (pneumothorax), system.
穴閉塞要素は血胸（ｈｅｍｏｔｈｏｒａｘ）を緩和する、システム。 25. The system of claim 24, wherein
Hole closure element to mitigate hemothorax (hemothorax), system.
組織を切開又は切除し得るようにされる、システム。 25. The system of claim 24, wherein
A system adapted to allow incision or excision of tissue .
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US58668304P | 2004-07-08 | 2004-07-08 | |
| US60/586,683 | 2004-07-08 | ||
| PCT/US2005/024173 WO2006014568A2 (en) | 2004-07-08 | 2005-07-08 | Lung device with sealing features |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008505709A JP2008505709A (en) | 2008-02-28 |
| JP2008505709A5 true JP2008505709A5 (en) | 2008-07-31 |
| JP4994230B2 JP4994230B2 (en) | 2012-08-08 |
Family
ID=35787659
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007520517A Expired - Fee Related JP4994230B2 (en) | 2004-07-08 | 2005-07-08 | Lung device with sealing function |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP4994230B2 (en) |
| CA (1) | CA2573148C (en) |
| WO (1) | WO2006014568A2 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101854960B (en) | 2006-12-15 | 2014-06-25 | 生命连结有限公司 | Gelatin-transglutaminase hemostatic dressings and sealants |
| AU2009261559B2 (en) | 2008-06-18 | 2014-01-16 | Lifebond Ltd | Improved cross-linked compositions |
| AU2010314992B2 (en) * | 2009-11-09 | 2016-09-15 | Spotlight Technology Partners Llc | Polysaccharide based hydrogels |
| CA2780274C (en) | 2009-11-09 | 2018-06-26 | Spotlight Technology Partners Llc | Fragmented hydrogels |
| CN102711853B (en) | 2009-12-22 | 2015-05-20 | 生命连结有限公司 | Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices |
| BR112012025498A2 (en) | 2010-04-05 | 2016-06-21 | Neomend Inc | device for releasing a multicomponent sealing compound, multicomponent syringe for releasing a sealing compound and method for releasing a sealing compound for a wound |
| DK2600910T3 (en) | 2010-08-05 | 2016-04-04 | Lifebond Ltd | Wound dressings and adhesives COMPREHENSIVE DRYING FORMATIONS |
| AU2019207781B2 (en) * | 2018-01-10 | 2024-08-15 | The Provost, Fellows, Scholars And Other Members Of Board Of Trinity College Dublin | System and methods for sealing a channel in tissue |
| US11998654B2 (en) | 2018-07-12 | 2024-06-04 | Bard Shannon Limited | Securing implants and medical devices |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5261889A (en) * | 1992-11-24 | 1993-11-16 | Boston Scientific Corporation | Injection therapy catheter |
| US5728133A (en) * | 1996-07-09 | 1998-03-17 | Cardiologics, L.L.C. | Anchoring device and method for sealing percutaneous punctures in vessels |
| US6152943A (en) * | 1998-08-14 | 2000-11-28 | Incept Llc | Methods and apparatus for intraluminal deposition of hydrogels |
| JP4953540B2 (en) * | 2000-02-24 | 2012-06-13 | ローマ リンダ ユニヴァーシティ メディカル センター | Patch and adhesive delivery system for closing tissue openings during surgery |
| US6770070B1 (en) * | 2000-03-17 | 2004-08-03 | Rita Medical Systems, Inc. | Lung treatment apparatus and method |
| US6736822B2 (en) * | 2002-02-20 | 2004-05-18 | Mcclellan Scott B. | Device and method for internal ligation of tubular structures |
| AU2003257180A1 (en) * | 2002-08-06 | 2004-02-23 | Matrix Medical, Llc | Biocompatible phase invertable proteinaceous compostions and methods for making and using the same |
-
2005
- 2005-07-08 CA CA2573148A patent/CA2573148C/en not_active Expired - Fee Related
- 2005-07-08 JP JP2007520517A patent/JP4994230B2/en not_active Expired - Fee Related
- 2005-07-08 WO PCT/US2005/024173 patent/WO2006014568A2/en active Application Filing
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008505709A5 (en) | ||
| JP7333425B2 (en) | Surgical method using purified amphipathic peptide composition | |
| JP5864429B2 (en) | Crosslinked hydrogel composition, method of forming hydrogel composition, and kit | |
| US10278700B2 (en) | Surgical device | |
| US5895412A (en) | Device and method for sealing tissue | |
| JP6092211B2 (en) | Surgical staples with topical additive coating | |
| US20090024068A1 (en) | Absorbable tissue dressing assemblies, systems, and methods formed from a Hydrophilic chitosan sponge structure and including a flexible absorbable backing layer of poly-4-hydroxy butyrate | |
| JP2024008978A (en) | System and methods for sealing channel in tissue | |
| EP2233157A1 (en) | A biocompatible denatured starch sponge material | |
| JP2008525127A5 (en) | ||
| EP3177330A1 (en) | Elastic biopolymer and use as a tissue adhesive | |
| JP2012152549A (en) | Hemostasis patch | |
| WO1997013461A9 (en) | Device and method for sealing tissue | |
| Schostek et al. | DC current pulses for OTSC clip fragmentation: technology and experimental study | |
| Bandi et al. | Comparison of blade temperature dynamics after activation of Harmonic Ace scalpel and the Ultracision Harmonic Scalpel LCS-K5 | |
| Crofton et al. | Effect of plasma sterilization on the hemostatic efficacy of a chitosan hemostatic agent in a rat model | |
| Ishihara et al. | Application of hydrogels as submucosal fluid cushions for endoscopic mucosal resection and submucosal dissection | |
| AU2011231246A1 (en) | Surgical fasteners and methods for sealing wounds | |
| KR102408275B1 (en) | Sol for closure of living tissue orifices, protection of ulcers and vascular embolization | |
| JP2020130536A (en) | Liquid polymeric compound composition and medical material | |
| Neath | Equipment and surgical instrumentation | |
| Kanehira et al. | Ultrasonically-activated devices for endoscopic surgery | |
| US20240261461A1 (en) | System and methods for using tissue-adhesive porous hemostatic products with minimally invasive surgical techniques | |
| RU2221515C2 (en) | Device for surgically treating the cases of tracheal stenosis | |
| Kirsch | Andrew Croftona, e, John Chrislerc, Samuel Hudsonf, Serkan Inceoglud, Floyd Petersene, and Wolff Kirsch* b, e |